
A look back at the impact of Hurricane Katrina on the dialysis community
Week in Review
(8/27)
Gambro to sell its peritoneal dialysis business to Fresenius
Top stories for Aug. 23 to 27
Week in Review
(8/20)
CMS releases final report on possible clinical performance measures
Top stories for Aug. 16 to 20
Week in Review
(8/13)
Financial incentives can improve performance, but can be difficult to implement
Top stories for Aug. 9 to 13
Week in Review
(8/6)
Jury sides with Fresenius in patent suit with Baxter
Top stories for Aug. 2 to 4
Week in Review
(7/30)
CMS released its much anticipated payment bundle for dialysis services
Top stories for July 26 to 30
(9/2)
Sexual dysfunction common but rarely studied in CKD patients
(9/2)
Lower blood pressure may preserve kidney function in some patients
(9/2)
Study singles out factors linked to cognitive deficits in type 2 diabetes
(9/2)
Study to look at effects of protein and exercise on dialysis patients
(9/2)
Baxter gets FDA warning over brochure for lung drug
(9/1)
Deal would provide dialysis to illegal immigrants in Atlanta
(8/31)
Investor wants Genzyme board to sell company
.jpg)
“Based on Sanofi’s letter and conference call, it is clear that the $69/share bid is simply a starting point for negotiations, and that their appraisal can move meaningfully higher as Genzyme demonstrates why it should. Consequently, we urge the Board to aggressively pursue the possible sale of the Company to Sanofi or any other companies that may express an interest in acquiring the firm.”
—David Katz of New York-based Matrix Asset Advisors, which holds about 320,000 shares of Genzyme
Renal Community
(8/24)
CMS slides from the Quality Improvement for the ESRD Program Open Door Forum
(8/18)
AAKP appoints new executive director
(8/17)
Fresenius Medical Care announces top 10 destinations for its dialysis patients
(8/10)
Fresenius announces winner of Ernestine M. Lowrie Award for Clinical Excellence
(8/5)
AAKP, Baxter to provide patient scholarships to national convention
Surveys/Rankings
(8/3)
Reviews of the ESRD payment bundle from renal advocacy groups
(8/3)
Investment Analysts' reports on the bundle
(12/1)
Renal community testimony at CMS Town Hall Meeting on ESRD bundling proposal
(11/19)
Report identifies recent transplant trends
(11/19)
Renal Physicians Association offers analysis of 2010 Medicare Physician Fee Schedule






